TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).

Ivan Titov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.